Skip to main content
. 2018 May 4;8:7062. doi: 10.1038/s41598-018-25571-w

Figure 1.

Figure 1

HMPC rescues C. elegans from MRSA infection. (A) Chemical structure of propyl 5-hydroxy-3-methyl-1-phenyl-1H-pyrazole-4-carbodithioate (HMPC). (B–D) Results of compound screening for C. elegans viability following S. aureus MW2 infection. A 384-well assay plate was co-inoculated with C. elegans, S. aureus MW2 and either 7 μg/ml HMPC (B); 100% survival), 10 μg/ml vancomycin (C) positive control; 100% survival), or 1% DMSO vehicle (D) negative control; 40% survival). Representative Sytox Orange-stained (right) and bright field (left) images from assay wells are shown. Only dead worms take up Sytox Orange and fluoresce. The images were first captured with an ImageExpress and further processed with CellProfiler to normalize the fluorescent or bright field intensity and to define the area of each worm.